White label – Pompe disease - ClinicalTrials.eu

A study of acalabrutinib and venetoclax for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have relapsed after initial treatment

Recruiting

2 1 1 1
Investigated Diseases:
- Chronic lymphocytic leukaemia recurrent
Investigated Drugs:
- Acalabrutinib
- Venetoclax
A study to evaluate the effectiveness of lenalidomide, pyrimethamine, and topiramate in reducing the HIV reservoir in people living with HIV.

Recruiting

2 1 1 1
Investigated Diseases:
- HIV infection
Investigated Drugs:
A study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.

Recruiting

3 1

+2
Study of K-924 (ezetimibe and pitavastatin) in patients with high cholesterol who have an inadequate response to pitavastatin

Recruiting

3 1 1
Investigated Diseases:
- Hypercholesterolaemia
Investigated Drugs:
- Ezetimibe
A study of PM54 and pembrolizumab in adults with advanced cancer

Recruiting

1 1 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
- Pembrolizumab
A study using [11C]ORM-13070 to examine the effects of aging and Parkinson’s disease on specific brain receptors.

Recruiting

2 1 1
Investigated Drugs:
- 1-[[(3S)-2,3-DIHYDRO-1,4-BENZODIOXIN-3-YL]METHYL]-4-[3-((11C)METHOXYMETHYL)-2-PYRIDINYL]PIPERAZINE
A study to compare continuous infusion and intermittent injections of furosemide and amiloride hydrochloride in patients hospitalized with acute heart failure and fluid overload

Recruiting

3 1 1 1
Investigated Diseases:
- Cardiac failure acute
Investigated Drugs:
- Amiloride Hydrochloride
- Furosemide
A study to evaluate the effect of CX11 trometamol monohydrate in patients with type 2 diabetes

Recruiting

2 1
Investigated Diseases:
- Type 2 diabetes mellitus
A study to evaluate the efficacy and safety of obinutuzumab compared to prednisolone in adults with newly onset minimal change disease

Recruiting

2 1 1 1
Investigated Diseases:
- Nephropathy
Investigated Drugs:
A study to evaluate the effectiveness of a drug combination in reducing respiratory tract infections in children aged 3 to 12 years.

Recruiting

3 1 1
Investigated Diseases:
- Respiratory tract infection
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies